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Supplementary Results
Supplementary Figures
Supplementary Figure S1 N2-(4-Aminobutyl)-1,3,5-triazine-2,4,6-triamine (S1). Title compound was prepared as described previously (1), in 80% yield. 
2-((4-Carboxyphenyl)amino)benzoic acid (S2).
Title compound was prepared as described previously (2) , with minor changes in the work-up procedure, in 70% yield. 258.1; found 258.1.
9-Oxo-9,10-dihydroacridine-2-carboxylic acid (S3). Title compound was prepared as described previously (3) , with minor changes in the work-up procedure, in 95% yield. 
9-Chloro-N-methylacridine-2-carboxamide (S5).
A round-bottom flask, equipped with a stir bar, was charged with S3 (375 mg, 1.6 mmol, 1 eq) and freshly distilled thionyl chloride (2 mL, 27.5 mmol , 17.2 eq). A catalytic amount of DMF was added and the solution was heated gently under reflux at 69 ºC, stirring until homogeneous and then for 1 h. The excess thionyl chloride was distilled off and the last traces were removed azeotropically via coevaporation with DCM (3 x 50 mL). The mixture was left under vacuum (minimally) for 1 hr to afford the crude intermediate, S4, as a yellow powder. solution of methylamine in methanol (0.9 mL, 1.8 mmol, 1.1 eq) was added and the solution was stirred at 0 ºC for 2 h and then slowly warmed to room temperature overnight. The solvent was removed by rotary evaporation and the crude mixture was purified via flash chromatography (SiO2; CH2Cl2:MeOH, 98:2 to 95:5) to yield a yellow solid (325 mg, 1.2 mmol, 75%). as described previously 4 , with minor changes, in 77% yield. 
2,2'-Iminodibenzoic (S9).
A round-bottom flask, equipped with a stir bar, was charged with 2-bromobenzoic acid (3.00 g, 14.9 mmol, 1 eq), anthranilic acid (2.25 g, 16.4 mmol, 1.1 eq), K2CO3 (6.00 g, 44 mmol, 2.95 eq), Cu (0.20 g, 2.9 mmol, 0.2 eq) and Cu2O (0.22 g, 1.45 mmol, 0.1 eq). To this mixture, anhydrous DMF (50 mL) was added and it was stirred at reflux at 130 ºC for 16 h. The work-up procedure was carried out as reported previously (5) 9-Oxo-9,10-dihydroacridine-4-carboxylic acid (S10). The title compound was prepared as described previously 3 , with minor changes in the work-up procedure, in 95% yield. Table. 1b where the forward flux through the two manifolds will be determine by this ratio:
Di-tert-
Supplementary Note 2
Because of the kinetic scheme, which includes two pathways, we cannot use the traditional definition of KI. We can, however, define the apparent IC50 as a concentration of the ligand at which 50% of MBNL1 is free. Apparent ; MBNL1 protein and (CUG)4 are shown as P and RNA, respectively.
We need to express IC50 in terms of known concentrations and equilibrium dissociation constants:
Equation (8) relates the apparent IC50 to the absolute concentrations of protein and RNA and to equilibrium dissociation constants. It is obvious that the amount of ligand required to observe half of the protein in the free form will greatly depend on actual concentrations of ligand and RNA. Thus, it will be potent under relatively narrow set of conditions (see paper for discussion). After the dissociation phase, the surface was regenerated, with a pulse of 0.5% SDS and/or 100 mM NaOH, for a few times followed by buffer wash to re-establish baseline. RU upon the injection of PBS buffer was subtracted from sensograms. For inhibition studies, the resulting sensograms were baselined at t = 120 s to offset the binding of small molecule to the immobilized RNA surface 
